Vitamin D receptor activation: Clinical outcomes

Contributions to Nephrology

Volumn 171, Issue , 2011, Pages 166-171

  Covic, Adrian ^a   Apetrii, Mugurel ^a  

^a C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL RECEPTOR; VITAMIN D;

ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; HUMAN; KIDNEY DISEASE; MORTALITY; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; RECEPTORS, CALCITRIOL; RENAL DIALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84925944508     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000327161     Document Type: Article

References (30)

1. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005;89:F8-F28. (Pubitemid 40863568)
2. Li YC, Kong J, Wei M, et al: 1,25- dihydroxyvitamin D(3) is a negative endocrine regulator of the renin- angiotensin system. J Clin Invest 2002;110:229-238. (Pubitemid 34787360)
3. Tabata T, Shoji T, Kikunami K, et al: In vivo effect of 1 alphahydroxyvitamin D3 on interleukin- 2 production in hemodialysis patients. Nephron 1988;50:295-298.
4. Tokuda N, Kano M, Meiri H, et al: Calcitriol therapy modulates the cellular immune responses in hemodialysis patients. Am J Nephrol 2000;20:129-137. (Pubitemid 30224023)
5. Xiang G, Seki T, Schuster MD, et al: Catalytic degradation of vitamin D up- regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem 2005;280:39394-39402. (Pubitemid 41713897)
6. Elstner E, Linker- Israeli M, Said J, et al: 20- epi- vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 1995;55:2822-2830.
7. Panichi V, De PS, Andreini B, et al: Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int 1998;54:1463-1469. (Pubitemid 28502888)
8. Aihara K, Azuma H, Akaike M, et al: Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:35798-35802. (Pubitemid 39100586)
9. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 2009;75:88-95.
10. Dobnig H, Pilz S, Scharnagl H, et al: Independent association of low serum 25- hydroxyvitamin D and 1,25- dihydroxyvitamin D levels with all- cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-1349. (Pubitemid 351930842)
11. Philippe Autier, Sara Gandini: Vitamin D supplementation and total mortality: a meta- analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-1737. (Pubitemid 47403059)
12. Barreto DV, Baretto FC, Liabeuf S, et al: Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1128-1135.
13. London GM, Guérin AP, Verbeke FH, et al: Mineral metabolism and arterial functions in end- stage renal disease: potential role of 25- hydroxyvitamin D deficiency. J Am Soc Nephrol 2007;18:613-620. (Pubitemid 46193327)
14. Drechsler C, Verduijn M, Pilz S, et al: Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study. Nephrol Dial Transplant 2011;26:1024-1032.
15. Shoji T, Kimoto E, Shinohara K, et al: Molecular forms of adiponectin in uraemic plasma. Nephrol Dial Transplant 2004;19:1937-1938. (Pubitemid 38961422)
16. Naves- Diaz M, Alvarez-Hernández D, Passlick- Deetjen J, et al: Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 2008;74:1070-1078.
17. Wolf M: Active vitamin D and survival. J Am Soc Nephrol 2008;19:1442-1443.
18. Shoben AB, Rudser KD, de Boer IH, et al: Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 2008;19:1613-1619.
19. Kovesdy CP, Ahmadzadeh S, Anderson JE, et al: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 2008;168:397-403. (Pubitemid 351350586)
20. Teng M, Wolf M, Lowrie E, et al: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-456. (Pubitemid 36910023)
21. Teng M, Wolf M, Ofsthun MN, et al: Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005;16:1115-1125. (Pubitemid 41710323)
22. Tentori F, Hunt WC, Stidley CA, et al: Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006;70: 1858-1865. (Pubitemid 44684819)
23. Kalantar- Zadeh K, et al: Survival predictability of time- varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006;70:771-780. (Pubitemid 44215354)
24. Shinaberger CS, Kopple JD and Kovesdy CP, et al: Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2008;3:1769-1776.
25. Kalantar- Zadeh K, et al: Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D and survival in hemodialysis patients. J Bone Miner Res 2010;25:2448-2458.
26. Dobrez DG, Mathes A, Amdahl M, et al: Paricalcitol- treated patients experience improved hospitalization outcomes compared with calcitrioltreated patients in real- world clinical settings. Nephrol Dial Transplant 2004;19:1174-1181. (Pubitemid 38628138)
27. Alborzi P, Patel NA, Peterson C, et al: Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double- blind pilot trial. Hypertension 2008;52:1-7.
28. Wu- Wong JR, Noonan W, Nakane M, et al: Vitamin D receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats. Int J Endocrinol 2010;2010:625852.
29. Stumpf WE, Sar M, Reid FA, et al: Target cells for 1,25- dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979; 206:1188-1190. (Pubitemid 10159658)
30. Andress DL: Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 2006;69:33-43. (Pubitemid 43117736)